The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glycated Albumin Assay Market Research Report 2025
Synopsis
Serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the glycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
The global Glycated Albumin Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glycated Albumin Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glycated Albumin Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glycated Albumin Assay include Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura and Leadman, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glycated Albumin Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Albumin Assay.
Report Scope
The Glycated Albumin Assay market size, estimations, and forecasts are provided in terms of sales volume (K Kit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycated Albumin Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycated Albumin Assay manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Segment by Type
Glycated Albumin (Human)
Glycated Albumin (Animal)
Segment by Application
Hospitals and Clinics
Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycated Albumin Assay manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycated Albumin Assay in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the glycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
The global Glycated Albumin Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glycated Albumin Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glycated Albumin Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glycated Albumin Assay include Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura and Leadman, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glycated Albumin Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Albumin Assay.
Report Scope
The Glycated Albumin Assay market size, estimations, and forecasts are provided in terms of sales volume (K Kit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycated Albumin Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycated Albumin Assay manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Segment by Type
Glycated Albumin (Human)
Glycated Albumin (Animal)
Segment by Application
Hospitals and Clinics
Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycated Albumin Assay manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycated Albumin Assay in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glycated Albumin Assay Market Overview
1.1 Product Overview and Scope of Glycated Albumin Assay
1.2 Glycated Albumin Assay Segment by Type
1.2.1 Global Glycated Albumin Assay Market Value Comparison by Type (2024-2030)
1.2.2 Glycated Albumin (Human)
1.2.3 Glycated Albumin (Animal)
1.3 Glycated Albumin Assay Segment by Application
1.3.1 Global Glycated Albumin Assay Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Laboratories
1.4 Global Glycated Albumin Assay Market Size Estimates and Forecasts
1.4.1 Global Glycated Albumin Assay Revenue 2019-2030
1.4.2 Global Glycated Albumin Assay Sales 2019-2030
1.4.3 Global Glycated Albumin Assay Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glycated Albumin Assay Market Competition by Manufacturers
2.1 Global Glycated Albumin Assay Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glycated Albumin Assay Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glycated Albumin Assay Average Price by Manufacturers (2019-2024)
2.4 Global Glycated Albumin Assay Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glycated Albumin Assay, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycated Albumin Assay, Product Type & Application
2.7 Glycated Albumin Assay Market Competitive Situation and Trends
2.7.1 Glycated Albumin Assay Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycated Albumin Assay Players Market Share by Revenue
2.7.3 Global Glycated Albumin Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycated Albumin Assay Retrospective Market Scenario by Region
3.1 Global Glycated Albumin Assay Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glycated Albumin Assay Global Glycated Albumin Assay Sales by Region: 2019-2030
3.2.1 Global Glycated Albumin Assay Sales by Region: 2019-2024
3.2.2 Global Glycated Albumin Assay Sales by Region: 2025-2030
3.3 Global Glycated Albumin Assay Global Glycated Albumin Assay Revenue by Region: 2019-2030
3.3.1 Global Glycated Albumin Assay Revenue by Region: 2019-2024
3.3.2 Global Glycated Albumin Assay Revenue by Region: 2025-2030
3.4 North America Glycated Albumin Assay Market Facts & Figures by Country
3.4.1 North America Glycated Albumin Assay Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glycated Albumin Assay Sales by Country (2019-2030)
3.4.3 North America Glycated Albumin Assay Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glycated Albumin Assay Market Facts & Figures by Country
3.5.1 Europe Glycated Albumin Assay Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glycated Albumin Assay Sales by Country (2019-2030)
3.5.3 Europe Glycated Albumin Assay Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycated Albumin Assay Market Facts & Figures by Country
3.6.1 Asia Pacific Glycated Albumin Assay Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glycated Albumin Assay Sales by Country (2019-2030)
3.6.3 Asia Pacific Glycated Albumin Assay Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glycated Albumin Assay Market Facts & Figures by Country
3.7.1 Latin America Glycated Albumin Assay Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glycated Albumin Assay Sales by Country (2019-2030)
3.7.3 Latin America Glycated Albumin Assay Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycated Albumin Assay Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycated Albumin Assay Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glycated Albumin Assay Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glycated Albumin Assay Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glycated Albumin Assay Sales by Type (2019-2030)
4.1.1 Global Glycated Albumin Assay Sales by Type (2019-2024)
4.1.2 Global Glycated Albumin Assay Sales by Type (2025-2030)
4.1.3 Global Glycated Albumin Assay Sales Market Share by Type (2019-2030)
4.2 Global Glycated Albumin Assay Revenue by Type (2019-2030)
4.2.1 Global Glycated Albumin Assay Revenue by Type (2019-2024)
4.2.2 Global Glycated Albumin Assay Revenue by Type (2025-2030)
4.2.3 Global Glycated Albumin Assay Revenue Market Share by Type (2019-2030)
4.3 Global Glycated Albumin Assay Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glycated Albumin Assay Sales by Application (2019-2030)
5.1.1 Global Glycated Albumin Assay Sales by Application (2019-2024)
5.1.2 Global Glycated Albumin Assay Sales by Application (2025-2030)
5.1.3 Global Glycated Albumin Assay Sales Market Share by Application (2019-2030)
5.2 Global Glycated Albumin Assay Revenue by Application (2019-2030)
5.2.1 Global Glycated Albumin Assay Revenue by Application (2019-2024)
5.2.2 Global Glycated Albumin Assay Revenue by Application (2025-2030)
5.2.3 Global Glycated Albumin Assay Revenue Market Share by Application (2019-2030)
5.3 Global Glycated Albumin Assay Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Asahi Kasei Pharma
6.1.1 Asahi Kasei Pharma Corporation Information
6.1.2 Asahi Kasei Pharma Description and Business Overview
6.1.3 Asahi Kasei Pharma Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Asahi Kasei Pharma Glycated Albumin Assay Product Portfolio
6.1.5 Asahi Kasei Pharma Recent Developments/Updates
6.2 DIAZYME
6.2.1 DIAZYME Corporation Information
6.2.2 DIAZYME Description and Business Overview
6.2.3 DIAZYME Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.2.4 DIAZYME Glycated Albumin Assay Product Portfolio
6.2.5 DIAZYME Recent Developments/Updates
6.3 Abnova
6.3.1 Abnova Corporation Information
6.3.2 Abnova Description and Business Overview
6.3.3 Abnova Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abnova Glycated Albumin Assay Product Portfolio
6.3.5 Abnova Recent Developments/Updates
6.4 LifeSpan
6.4.1 LifeSpan Corporation Information
6.4.2 LifeSpan Description and Business Overview
6.4.3 LifeSpan Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LifeSpan Glycated Albumin Assay Product Portfolio
6.4.5 LifeSpan Recent Developments/Updates
6.5 Exocell
6.5.1 Exocell Corporation Information
6.5.2 Exocell Description and Business Overview
6.5.3 Exocell Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Exocell Glycated Albumin Assay Product Portfolio
6.5.5 Exocell Recent Developments/Updates
6.6 BSBE
6.6.1 BSBE Corporation Information
6.6.2 BSBE Description and Business Overview
6.6.3 BSBE Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BSBE Glycated Albumin Assay Product Portfolio
6.6.5 BSBE Recent Developments/Updates
6.7 Medicalsystem
6.6.1 Medicalsystem Corporation Information
6.6.2 Medicalsystem Description and Business Overview
6.6.3 Medicalsystem Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medicalsystem Glycated Albumin Assay Product Portfolio
6.7.5 Medicalsystem Recent Developments/Updates
6.8 Maccura
6.8.1 Maccura Corporation Information
6.8.2 Maccura Description and Business Overview
6.8.3 Maccura Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Maccura Glycated Albumin Assay Product Portfolio
6.8.5 Maccura Recent Developments/Updates
6.9 Leadman
6.9.1 Leadman Corporation Information
6.9.2 Leadman Description and Business Overview
6.9.3 Leadman Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Leadman Glycated Albumin Assay Product Portfolio
6.9.5 Leadman Recent Developments/Updates
6.10 Simes Sikma
6.10.1 Simes Sikma Corporation Information
6.10.2 Simes Sikma Description and Business Overview
6.10.3 Simes Sikma Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Simes Sikma Glycated Albumin Assay Product Portfolio
6.10.5 Simes Sikma Recent Developments/Updates
6.11 NINGBO PUREBIO
6.11.1 NINGBO PUREBIO Corporation Information
6.11.2 NINGBO PUREBIO Glycated Albumin Assay Description and Business Overview
6.11.3 NINGBO PUREBIO Glycated Albumin Assay Sales, Revenue and Gross Margin (2019-2024)
6.11.4 NINGBO PUREBIO Glycated Albumin Assay Product Portfolio
6.11.5 NINGBO PUREBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycated Albumin Assay Industry Chain Analysis
7.2 Glycated Albumin Assay Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycated Albumin Assay Production Mode & Process
7.4 Glycated Albumin Assay Sales and Marketing
7.4.1 Glycated Albumin Assay Sales Channels
7.4.2 Glycated Albumin Assay Distributors
7.5 Glycated Albumin Assay Customers
8 Glycated Albumin Assay Market Dynamics
8.1 Glycated Albumin Assay Industry Trends
8.2 Glycated Albumin Assay Market Drivers
8.3 Glycated Albumin Assay Market Challenges
8.4 Glycated Albumin Assay Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
